Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability (CampAir FEA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02816216|
Recruitment Status : Completed
First Posted : June 28, 2016
Last Update Posted : January 30, 2017
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Behavioral: CampAir||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||14 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Mobile Technology and Online Tools to Improve Asthma Control in Adolescents|
|Actual Study Start Date :||May 1, 2016|
|Actual Primary Completion Date :||October 5, 2016|
|Actual Study Completion Date :||October 5, 2016|
End User Iterative Testing - CampAir
To ensure the software and website function as intended, investigators will systematically test each of the seven CampAir modules with target end users. Participants will review one module per week for seven weeks. As part of each module, participants will also complete a daily asthma checklist. Following the review of each module, participants will be prompted to complete measures assessing technology acceptability and usability and product quality. Results will be used to modify and finalize the user interface and navigation to maximize usability.
An empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control.
- Product Evaluation [ Time Frame: Once per module (One Evaluation per week for seven weeks) ]Participants will complete a brief online survey to rate the content modules and other components of the CampAir program in the areas of (a) engagement, (b) quality of content, (c) quality of flow, (d) value, (e) usefulness, (f) relevance to real-life, (g) usability. Open-ended questions will also be included to gather qualitative comments and recommendations for each area assessed. This measure will be repeated for each review with questions tailored to the particular components and modules reviewed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02816216
|United States, North Carolina|
|3-C Institute for Social Development|
|Durham, North Carolina, United States, 27713|
|Principal Investigator:||Janey S McMillen, PhD||3-C Institute for Social Development|